Clinical Trial Update: Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease (DEcIDED) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the intracanalicular dexamethasone insert for inflammation and discomfort in dry eye disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• Dexamethasone intracanalicular insert (dexamethasone intracanalicular insert)

Snippet

Sponsor: Tufts Medical Center | Conditions: Dry Eye | Phase 4 | Status: TERMINATED